Enterprise Value
24.43M
Cash
6.562M
Avg Qtr Burn
-9.242M
Short % of Float
5.98%
Insider Ownership
3.06%
Institutional Own.
18.65%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
IBIO-200/202 Details COVID-19 | Failed Discontinued |